Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01640236 · ClinicalTrials.gov registry record
Flare Measurements in Human Radiation Therapy Patients
A clinical trial of The Impact of Whole Body Irradiation on Ocular Flare, sponsored by ChromoLogic.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT01640236 is a study of The Impact of Whole Body Irradiation on Ocular Flare that has completed, run by ChromoLogic. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01640236, a study of The Impact of Whole Body Irradiation on Ocular Flare, has completed, sponsored by ChromoLogic.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a longitudinal Feasibility Study of a novel non-invasive device in assessing radiation dose exposure in humans. All patients receiving whole body irradiation therapy and meeting all other inclusion/exclusion criteria will receive ocular flare meter measurements and slit-lamp examinations on up to eleven occasions starting prior to the first fractional dose of irradiation.
Conditions Studied
Study Locations (1)
California
- UCLA Radiation Oncology - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01640236
The ClinicalTrials.gov registry entry for NCT01640236 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ChromoLogic, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with The Impact of Whole Body Irradiation on Ocular Flare appearing as the primary indexed condition, and to 0 interventions.
NCT01640236 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01640236 about?
NCT01640236 is a clinical study titled "Flare Measurements in Human Radiation Therapy Patients". This is a longitudinal Feasibility Study of a novel non-invasive device in assessing radiation dose exposure in humans. All patients receiving whole body irradiation therapy and meeting all other inclusion/exclusion criteria will receive ocular flare meter measurements and slit-lamp examinations on ...
What is the current status of trial NCT01640236?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-07. Estimated completion is 2014-07.
What conditions does trial NCT01640236 study?
This clinical trial studies the following conditions: The Impact of Whole Body Irradiation on Ocular Flare.
Who is sponsoring clinical trial NCT01640236?
This trial is sponsored by ChromoLogic, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01640236 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.